Gene · 25937
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CUDC-907 exerts an inhibitory effect on non-small cell lung cancer associated with induction of mitotic catastrophe and downregulation of YAP/TAZ signaling. | Chem Biol Interact | 2025 | 40935272 | PubTator, text mining | PubMed |
| Case Report: A case of epithelioid hemangioendothelioma of the right femoral artery misdiagnosed as arterial occlusion. | Front Surg | 2025 | 40896782 | PubTator, text mining | PubMed |
| The components and regulation of the Hippo pathway and its relationships with the progression and treatment of Non-small cell lung cancer (NSCLC). | Cancer Cell Int | 2025 | 40830878 | PubTator, text mining | PubMed |
| Atorvastatin exhibits anticancer effects by inhibiting YAP/TAZ activity in mesenchymal-like non-small cell lung cancer. | Sci Rep | 2025 | 40826167 | PubTator, text mining | PubMed |
| Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth. | Nat Commun | 2025 | 40759645 | PubTator, text mining | PubMed |
| The complex conundrum of Merkel cell carcinoma cellular ancestry. | Cell Death Dis | 2025 | 40730805 | PubTator, text mining | PubMed |
| Injinoryeong-San attenuates metabolic dysfunction-associated steatohepatitis via regulation of YAP/TAZ-signaling pathway. | J Ethnopharmacol | 2025 | 40683423 | PubTator, text mining | PubMed |
| Acoustic technologies for the orchestration of cellular functions for therapeutic applications. | Sci Adv | 2025 | 40680134 | PubTator, text mining | PubMed |
| CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer. | bioRxiv | 2025 | 40667288 | PubTator, text mining | PubMed |
| The polarity protein Par3 enhances renal cell carcinoma metastasis via YAP/TAZ activation. | Cancer Biol Med | 2025 | 40626835 | PubTator, text mining | PubMed |
| Discovery of 2-Pyrazolylpyrimidinone Derivatives as New SPOP Inhibitors for Renal Cell Carcinoma Therapy. | J Med Chem | 2025 | 40622869 | PubTator, text mining | PubMed |
| Insights to phytochemistry, analytical methods, pharmacological activities, stability, and specifications of alantolactone. | Fitoterapia | 2025 | 40617333 | PubTator, text mining | PubMed |
| Gene Fusions as Potential Therapeutic Targets in Soft Tissue Sarcomas. | Biomolecules | 2025 | 40563544 | PubTator, text mining | PubMed |
| Local C1q/TNF-related protein 1 attenuates kidney inflammation and fibrosis by regulating macrophage activation. | Am J Physiol Renal Physiol | 2025 | 40424084 | PubTator, text mining | PubMed |
| Mechanisms underlying obesity-malignancy connection: a systematic narrative review. | J Physiol Biochem | 2025 | 40408050 | PubTator, text mining | PubMed |
| Effects of melatonin in polycystic ovary syndrome: is there Hippo pathway crosstalk? | J Ovarian Res | 2025 | 40369589 | PubTator, text mining | PubMed |
| Wogonin potentiates the irradiation effect on hepatocellular carcinoma by activating the Hippo-Yes-associated protein/transcriptional co-activator with PDZ-binding motif pathway. | Int Immunopharmacol | 2025 | 40318272 | PubTator, text mining | PubMed |
| A case of hepatic epithelioid hemangioendothelioma with features resembling those of acute-onset autoimmune hepatitis that was undiagnosed before liver transplantation. | Clin J Gastroenterol | 2025 | 40146463 | PubTator, text mining | PubMed |
| The Hippo pathway effector YAP inhibits NF-κB signaling and ccRCC growth by opposing ZHX2. | J Biol Chem | 2025 | 40120683 | PubTator, text mining | PubMed |
| BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target. | Sci Rep | 2025 | 40038391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25937/papers?page=5